http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 26 Aug 2026 16:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/First+Tracks+Biotherapeutics+Announces+Participation+in+September+Investor+Conferences/26981903.html <p align="left">SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:</p> <p><strong>21</strong>^{<strong>st</strong>}<strong> Annual Wells Fargo Healthcare Conference, Boston</strong></p> <ul type="disc"><li>Format – Fireside chat and one-on-one investor meetings</li><li>Date and Time – Wednesday, Sept. 9, 2026 at 9:30am ET / 6:30am PT</li></ul> <p><strong>Citi's 2026 Biopharma Back to School Conference, New York City</strong></p> <ul type="disc"><li>Format – One-on-one investor meetings</li><li>Date http://www.streetinsider.com/Press+Releases/First+Tracks+Biotherapeutics+Announces+Participation+in+September+Investor+Conferences/26981903.html Wed, 26 Aug 2026 16:15:00 -0400 TRAX http://www.streetinsider.com/Globe+Newswire/First+Tracks+Biotherapeutics+Announces+Participation+in+September+Investor+Conferences/26981903.html <p align="left">SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:</p> <p><strong>21</strong>^{<strong>st</strong>}<strong> Annual Wells Fargo Healthcare Conference, Boston</strong></p> <ul type="disc"><li>Format – Fireside chat and one-on-one investor meetings</li><li>Date and Time – Wednesday, Sept. 9, 2026 at 9:30am ET / 6:30am PT</li></ul> <p><strong>Citi's 2026 Biopharma Back to School Conference, New York City</strong></p> <ul type="disc"><li>Format – One-on-one investor meetings</li><li>Date http://www.streetinsider.com/Globe+Newswire/First+Tracks+Biotherapeutics+Announces+Participation+in+September+Investor+Conferences/26981903.html Wed, 26 Aug 2026 16:15:00 -0400 TRAX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html si-local-file:///var/storage/secattach/20260818/26944186.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html Tue, 18 Aug 2026 16:06:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html si-local-file:///var/storage/secattach/20260818/26944186.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html Tue, 18 Aug 2026 16:06:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html si-local-file:///var/storage/secattach/20260818/26944186.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html Tue, 18 Aug 2026 16:06:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html si-local-file:///var/storage/secattach/20260818/26944164.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html si-local-file:///var/storage/secattach/20260818/26944164.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html si-local-file:///var/storage/secattach/20260818/26944164.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html si-local-file:///var/storage/secattach/20260818/26944169.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html si-local-file:///var/storage/secattach/20260818/26944169.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html si-local-file:///var/storage/secattach/20260818/26944169.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/New+Coverage/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html <p>Wolfe Research analyst Andy Chen initiates coverage on First Tracks Biotherapeutics (NASDAQ: TRAX) with a Outperform rating and a price target of $83.00.</p><p>The analyst comments "Three assets. The CD122 likely accounts for majority of EV after FBRX acquisition (report). The BDCA2 is early, a small contributor due to new mechanism in a challenging disease (lupus). The PD-1 likely contributing to near-zero in stock due to strong buyside dislike of the RA data. One (CD122), new mechanism in Celiac, not yet clear if better efficacy or equal safety compared to aIL-15. Last week, we previewed argenx's CD122 Ph2 (report), and foresee http://www.streetinsider.com/New+Coverage/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html Tue, 18 Aug 2026 05:39:20 -0400 TRAX http://www.streetinsider.com/Analyst+Comments/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html <p>Wolfe Research analyst Andy Chen initiates coverage on First Tracks Biotherapeutics (NASDAQ: TRAX) with a Outperform rating and a price target of $83.00.</p><p>The analyst comments "Three assets. The CD122 likely accounts for majority of EV after FBRX acquisition (report). The BDCA2 is early, a small contributor due to new mechanism in a challenging disease (lupus). The PD-1 likely contributing to near-zero in stock due to strong buyside dislike of the RA data. One (CD122), new mechanism in Celiac, not yet clear if better efficacy or equal safety compared to aIL-15. Last week, we previewed argenx's CD122 Ph2 (report), and foresee http://www.streetinsider.com/Analyst+Comments/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html Tue, 18 Aug 2026 05:39:20 -0400 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html si-local-file:///var/storage/secattach/20260814/26931403.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html Fri, 14 Aug 2026 16:31:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html si-local-file:///var/storage/secattach/20260814/26931403.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html Fri, 14 Aug 2026 16:31:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html si-local-file:///var/storage/secattach/20260814/26925207.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html Fri, 14 Aug 2026 08:34:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html si-local-file:///var/storage/secattach/20260814/26925207.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html Fri, 14 Aug 2026 08:34:00 -0400 O.77374830 TRAX http://www.streetinsider.com/Earnings/First+Tracks+Biotherapeutics%2C+Inc.+%28TRAX%29+Reports+Q2+Loss+of+%240.95/26921470.html <p>First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) reported Q2 EPS of ($0.95).</p><p>For earnings history and earnings-related data on First Tracks Biotherapeutics, Inc. (TRAX) <a href="http://www.streetinsider.com/ec_earnings.php?q=TRAX">click here</a>.</p> http://www.streetinsider.com/Earnings/First+Tracks+Biotherapeutics%2C+Inc.+%28TRAX%29+Reports+Q2+Loss+of+%240.95/26921470.html Thu, 13 Aug 2026 16:19:01 -0400 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html si-local-file:///var/storage/secattach/20260813/26921071.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html Thu, 13 Aug 2026 16:11:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html si-local-file:///var/storage/secattach/20260813/26921071.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html Thu, 13 Aug 2026 16:11:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html si-local-file:///var/storage/secattach/20260813/26920809.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html Thu, 13 Aug 2026 16:06:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html si-local-file:///var/storage/secattach/20260813/26920809.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html Thu, 13 Aug 2026 16:06:00 -0400 O.77374830 TRAX http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html (Updated - August 13, 2026 9:24 AM EDT) <p>Piper Sandler analyst Yasmeen Rahimi raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $95.00 (from $54.00) while maintaining an Overweight rating.</p><p>The analyst commented: "We had a chance to catch up with TRAX following 2Q26 earnings where they detailed how ANB033's Ph1b CeD Cohort 1 enrollment is complete with data remaining on-track for 4Q26. With this, mgmt explained their rationale behind adjusting the Cohort 2 enrollment to include a Vh:Cd <2.5 (vs <2.0) and any symptoms at baseline in order to evaluate ANB033's effect on mucosal healing in a broader patient http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html Thu, 13 Aug 2026 09:24:17 -0400 TRAX http://www.streetinsider.com/Analyst+Comments/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html (Updated - August 13, 2026 9:24 AM EDT) <p>Piper Sandler analyst Yasmeen Rahimi raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $95.00 (from $54.00) while maintaining an Overweight rating.</p><p>The analyst commented: "We had a chance to catch up with TRAX following 2Q26 earnings where they detailed how ANB033's Ph1b CeD Cohort 1 enrollment is complete with data remaining on-track for 4Q26. With this, mgmt explained their rationale behind adjusting the Cohort 2 enrollment to include a Vh:Cd <2.5 (vs <2.0) and any symptoms at baseline in order to evaluate ANB033's effect on mucosal healing in a broader patient http://www.streetinsider.com/Analyst+Comments/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html Thu, 13 Aug 2026 09:24:17 -0400 TRAX http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2457+at+H.C.+Wainwright/26916108.html H.C. Wainwright analyst Emily Bodnar raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $57.00 (from $44.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2457+at+H.C.+Wainwright/26916108.html Thu, 13 Aug 2026 06:55:27 -0400 TRAX